CLINICAL TRIALS PROFILE FOR DIMETHYL SULFOXIDE
✉ Email this page to a colleague
All Clinical Trials for dimethyl sulfoxide
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00118313 ↗ | Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma | Completed | National Cancer Institute (NCI) | Phase 1 | 2004-11-04 | RATIONALE: Vaccines made from peptides may help the body build an effective immune response to kill tumor cells. Biological therapies, such as imiquimod, may stimulate the immune system in different ways and stop tumor cells from growing. Giving vaccine therapy together with imiquimod after surgery may help the body kill any remaining tumor cells. PURPOSE: This randomized phase I trial is studying the side effects and best way to give vaccine therapy with or without imiquimod in treating patients who have undergone surgery for stage II, stage III, or stage IV melanoma. |
NCT00118313 ↗ | Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma | Completed | Craig L Slingluff, Jr | Phase 1 | 2004-11-04 | RATIONALE: Vaccines made from peptides may help the body build an effective immune response to kill tumor cells. Biological therapies, such as imiquimod, may stimulate the immune system in different ways and stop tumor cells from growing. Giving vaccine therapy together with imiquimod after surgery may help the body kill any remaining tumor cells. PURPOSE: This randomized phase I trial is studying the side effects and best way to give vaccine therapy with or without imiquimod in treating patients who have undergone surgery for stage II, stage III, or stage IV melanoma. |
NCT00317070 ↗ | Trial Comparing Intravesical Cocktail With Intravesical Dimethyl Sulfoxide (DMSO) in Painful Bladder Syndrome/Interstitial Cystitis (PBS/IC) | Terminated | Nova Scotia Health Authority | Phase 2 | 2006-04-01 | The primary objective of this study is to evaluate the efficacy and tolerability of the intravesical cocktail and its comparison with intravesical DMSO in a controlled trial for the treatment of painful bladder syndrome including interstitial cystitis. |
NCT00388687 ↗ | Hypoxia Imaging With 18F FAZA. Prognostic Impact in Cervical Cancer | Unknown status | Medical University of Vienna | 2006-07-01 | The aim of this study is to visualize the tumor hypoxic tissue, the potential quantitative changes and the biological behavior of cervical carcinoma (primary and / or lymph nodes) before, during and after radiochemotherapy with the novel hypoxia PET tracer 18FAZA. | |
NCT00583219 ↗ | Botulin-A Toxin Instillations and Overactive Bladder | Completed | Mayo Clinic | Phase 1/Phase 2 | 2006-03-01 | The primary objective of this pilot study is to evaluate the safety and efficacy of direct instillations of Botulinum-A toxin/DMSO into the bladder via a catheter system as a means of treating women with symptoms of overactive bladder and secondary urinary incontinence. In doing so, we will focus on estimating the percentage of women who experience an improvement in their urinary incontinence symptoms at one month and three months following this novel instillation technique. |
NCT00667095 ↗ | Over Active Bladder Instillation Study - Botox | Terminated | Mayo Clinic | Phase 3 | 2008-04-01 | The purpose of this study is to determine whether women with overactive bladder (OAB) who receive direct instillation via a catheter of a Botulinum-A Toxin (Botox) with Dimethyl Sulfoxide (DMSO) solution experience significantly better improvement of their OAB symptoms when compared to a similar group of women with OAB who receive instillation of DMSO only. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for dimethyl sulfoxide
Condition Name
Clinical Trial Locations for dimethyl sulfoxide
Trials by Country
Clinical Trial Progress for dimethyl sulfoxide
Clinical Trial Phase
Clinical Trial Sponsors for dimethyl sulfoxide
Sponsor Name